Skip to content
Skip to navigation
Skip to footer

Archive

View global media contacts

Home / Media Centre / Archive

Here you can find the archive of all Press Releases prior to 2022

Filter by date:

Showing 1107 press releases before 2022

AstraZeneca highlights latest advances in lung cancer at the ESMO 2017 Congress
31 August 2017
AstraZeneca and Takeda establish collaboration to develop and commercialise MEDI1341 for Parkinson’s disease
29 August 2017
Faslodex receives US FDA approval as monotherapy for expanded use in breast cancer
28 August 2017
Extended treatment with Brilinta reduces risk of cardiovascular death by 29% in patients with history of heart attack
24 August 2017
Lynparza receives additional and broad approval in the US for ovarian cancer
17 August 2017
US FDA accepts regulatory submission for acalabrutinib and grants Priority Review
2 August 2017
Acalabrutinib granted Breakthrough Therapy Designation by US FDA for the treatment of patients with mantle cell lymphoma
1 August 2017
Imfinzi granted Breakthrough Therapy Designation by US FDA for patients with locally-advanced unresectable non-small cell lung cancer
31 July 2017
Tagrisso significantly improves progression-free survival in the Phase III FLAURA trial for lung cancer
27 July 2017
AstraZeneca reports initial results from the ongoing MYSTIC trial in Stage IV lung cancer
27 July 2017

<
1
2
3
111
>

All of our latest press releases and articles are available to explore